NAGE Q4 2018 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+20.4% YoY

Gross Profit

$5M52.0% margin

Operating Income

-$8M-90.9% margin

Net Income

-$8M-90.6% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+11.7%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$42M

Total Liabilities

$15M

Stockholders' Equity

$27M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$8M	+20.4%
Gross Profit	$5M	$4M	+22.8%
Operating Income	-$8M	-$9M	+6.1%
Net Income	-$8M	-$9M	+6.8%